Back to CVE records
Medium 5.4Published Aug 31, 2025

CVE-2025-9718A security flaw has been discovered in O2OA up to 10.0-410.

Updated under an hour ago ()

This data is behind schedule: last updated 2026-10-22 20:23 UTC. We are working on it.Behind: National Vulnerability Database (CVE API 2.0, CPE API 2.0).

Does this affect you?

It affects zoneland o2oa. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

A security flaw has been discovered in O2OA up to 10.0-410. This affects an unknown part of the file /x_processplatform_assemble_designer/jaxrs/process of the component Personal Profile Page. Performing manipulation of the argument name/alias results in cross site scripting. Remote exploitation of the attack is possible. The exploit has been released to the public and may be exploited. The vendor replied in the GitHub issue (translated from simplified Chinese): "This issue will be fixed in the new version."

CVSS
5.4 MEDIUM (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
Weakness (CWE)
CWE-79, CWE-94
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
Not given
NVD analysis
Analyzed
Record last updated
Oct 19, 2026
First seen by InfoSec Signals
Oct 19, 2026

Affected products

Affected products
zoneland o2oa
zoneland:o2oa
through 10.0-410
NVD

References

  • exploit, issue-tracking, third-party-advisory
  • exploit, issue-tracking, third-party-advisory
  • exploit, issue-tracking, third-party-advisory
  • permissions-required, vdb-entry
  • third-party-advisory, vdb-entry
  • third-party-advisory, vdb-entry

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.